Skip to main content
. 2020 Sep 30;18(4):792–804. doi: 10.1038/s41423-020-00555-x

Fig. 1.

Fig. 1

a Annual changes in the number of registered CAR T clinical trials and the phases of current trials. b Current registered CAR T trials for hematologic malignancies in China. c Current registered CAR T trials for solid tumors in China